Changes to opioid prescribing now in place

Several changes to the regulation of the supply of prescription opiods in Australia came into effect on 1 June. 

The new rules – including requiring pharmaceutical companies to offer reduced pack sizes and restrictions around prescribing – are part of a range of changes planned for prescription opioid medicines to be phased in. There will also be various changes to the Pharmaceutical Benefits Scheme (PBS) to support the regulatory changes.

The changes come in response to the to the growing number of deaths involving prescription opioids in Australia. From 2007 to 2016, opioid-related deaths nearly doubled – from 591 to 1,119 deaths per year. Click here for more information.